Citations

Mayo Clinic

Showing 10 of 108602 citations.

“Trident Sign” in Spinal Cord Lymphoma (P7-4.003)
Griffin, Kim, Tolédano, Michel B. , Toledano, Michel, Flanagan, Eoin P. , Mustafa, Rafid

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201918 Get It

Sex and Gender Differences Influence Urinary Symptoms and Management in Multiple System Atrophy (P8-9.001)
Schipani, Elke , Sandroni, Paola , Benarroch, Eduardo E. , Bower, James , Low, Phillip A. , Hooshmand, Sara, Badihian, Negin , Bower, James, Singer, Wolfgang , Coon, Elizabeth A.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201904 Get It

Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment (P7-12.004)
Kymes, Steven, Talon, Brian , Cady, Roger, Asher, Divya , Karnik-Henry, Meghana, Mulvihill, Emily , Bates, Dawn, Beusterien, Kathleen , Schwedt, Todd J. , Martin, Ashley , Lee, Xin Ying , Karnik‐Henry, Meghana

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201891 Get It

Early Clinical Experience With Eptinezumab From a Retrospective, Observational Study of Real-World Patient Response (P6-12.008)
Starling, Amaal J. , Kymes, Steven, Asher, Divya , Soni-Brahmbhatt, Seema , Karnik-Henry, Meghana, Karnik‐Henry, Meghana

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201880 Get It

Sural Nerve Biopsy Assessment by Individual Histologic Preparations: An Observational Cohort Study of 100 Consecutive Cases (P11-8.001)
Soontrapa, Pannathat , Dyck, P. James B. , Engelstad, JaNean , Davies, Jenny , Harmsen, William S. , Mandrekar, Jayawant N. , Spinner, Robert J. , Shelly, Shahar , Ida, Cristiane M. , Klein, Christopher J.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201860 Get It

Decline in Visual and Posterior Cortical Functions in Logopenic Progressive Aphasia (P5-6.001)
Graff‐Radford, Jonathan , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Singh, Neha Atulkumar , Carlos, Arenn F. , Machulda, Mary M. , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R. , Whitwell, Jennifer L.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201840 Get It

Chorea Associated with Lamotrigine Use: A case report, retrospective chart review, and literature summary (P2-11.014)
Hanson, Sofia, Badihian, Negin , Smith, Kelsey R. , Coon, Elizabeth A.

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201778 Get It

Financial Burden of Multiple Sclerosis Hospitalizations; A National Study during 2009–2019 in the United States. (P3-3.007)
Yadollahi, Sepideh, Movassagh, Radbod, Seifi, Ali

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201776 Get It

Reduced Slow-Wave Sleep and Severe Sleep Apnea are Associated with Neuroimaging Biomarkers of Cerebrovascular Disease (S6.004)
Przybelski, Scott A. , Petersen, Ronald C. , Clifford, Jack, Graff-Radford, Jonathan, Carvalho, Diego, McCarter, Stuart J. , Louis, Erik K. St. , Morgenthaler, Timothy I. , Boeve, Bradley F. , Graff‐Radford, Jonathan , Vemuri, Prashanthi

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201735 Get It

Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift
Aedo-Lopez, Veronica , Block, Matthew S. , Amaria, Rodabe N. , Hieken, Tina J. , Kreidieh, Firas , McArthur, Grant A.

American Society of Clinical Oncology Educational Book | April 28, 2023 | Volume: No volume available | Issue: 43 | Pages: No page available

10.1200/edbk_390614 | PMID 37116111 Get It

Clinical stage III melanoma, defined as resectable RECIST measurable nodal disease with or without in-transit metastases, represents approximately 15% of new melanoma diagnoses every year with additional cases presenting as recurrent nodal disease following previous treatment of a primary melanoma. The standard of care for patients with resectable clinical stage III melanoma is surgical resection, consisting of therapeutic lymph node dissection and/or resection of in-transit disease and consideration of adjuvant systemic therapy and occasionally adjuvant radiation. These patients have high rates of regional recurrence and progression to metastatic disease postsurgery, highlighting the need for better treatment options. With the success of immune checkpoint inhibitors in both the adjuvant and metastatic settings, the use of these agents in the neoadjuvant setting has been an emerging area of research interest. In this chapter, we will discuss the rationale for neoadjuvant immunotherapy; review impactful clinical trials; and define response monitoring, surgical considerations, emerging therapies, and unanswered questions for neoadjuvant therapy as a recent paradigm shift in the management of clinical stage III melanoma.